Renaissance Group’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-21,184
Closed -$1.03M 285
2022
Q4
$1.03M Sell
21,184
-149
-0.7% -$9.35K 0.05% 200
2022
Q3
$1.5M Buy
21,333
+708
+3% +$60.6K 0.08% 126
2022
Q2
$1.46M Buy
20,625
+1,078
+6% +$69.5K 0.08% 123
2022
Q1
$1.56M Buy
+19,547
New +$1.46M 0.07% 128
2020
Q3
Sell
-23,436
Closed -$1.44M 246
2020
Q2
$1.44M Buy
23,436
+206
+0.9% +$8.41K 0.07% 110
2020
Q1
$749K Buy
+23,230
New +$783K 0.04% 127

Other funds holding STAA

Renaissance Group's STAA Position: Q1 2023 in Review

Renaissance Group sold out of STAAR Surgical (STAA) in Q1 2023, closing a stake of 21,184 shares — an estimated $1.03M sold.

Renaissance Group first reported a position in STAA in Q1 2020 and held it in 6 quarters. The position peaked at $1.56M in Q1 2022. 251 funds tracked by Wall St. Rank hold STAA as of Q1 2023.

  • Renaissance Group reported no remaining STAAR Surgical position as of Q1 2023 after selling out during the quarter.
  • Renaissance Group sold 21,184 STAAR Surgical shares in Q1 2023, an estimated $1.03M.
  • Renaissance Group first reported a position in STAAR Surgical in Q1 2020 and held it in 6 quarters.
  • Renaissance Group's STAAR Surgical position peaked at $1.56M in Q1 2022.
  • 251 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2023.

Based on Renaissance Group's 13F filing for Q1 2023, filed 12 May 2023.